Analytical assessment of clinical sensitivity and specificities of pharmaceutical rapid SARS-CoV-2 detection nasopharyngeal swab testing kits in Pakistan

Abstract Despite of the global unity against COVID-19 pandemic, the threat of SARS-CoV-2 variants on the lives of human being is still not over. SARS-CoV-2 pandemic has urged the need of rapid viral detection at earliest. To cope with gradually expanding scenario of SARS-CoV-2, accurate diagnosis is...

Full description

Bibliographic Details
Main Authors: U. Saeed, R. Uppal, A. A. Khan, M. R. Uppal, Z. Z. Piracha, S. R. Uppal
Format: Article
Language:English
Published: Instituto Internacional de Ecologia 2024-03-01
Series:Brazilian Journal of Biology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1519-69842024000101101&lng=en&tlng=en
_version_ 1797277080101060608
author U. Saeed
R. Uppal
A. A. Khan
M. R. Uppal
Z. Z. Piracha
S. R. Uppal
author_facet U. Saeed
R. Uppal
A. A. Khan
M. R. Uppal
Z. Z. Piracha
S. R. Uppal
author_sort U. Saeed
collection DOAJ
description Abstract Despite of the global unity against COVID-19 pandemic, the threat of SARS-CoV-2 variants on the lives of human being is still not over. SARS-CoV-2 pandemic has urged the need of rapid viral detection at earliest. To cope with gradually expanding scenario of SARS-CoV-2, accurate diagnosis is extremely crucial factor which should be noticed by international health organizations. Limited research followed by sporadic marketing of SARS-CoV-2 rapid pharmaceutical detection kits raises critical questions against quality assurance and quality control measures. Herein we aimed to interrogate effectivity and specificity analysis of SARS-CoV-2 pharmaceutical rapid detection kits (nasopharyngeal swab based) using conventional gold standard triple target real-time polymerase chain reaction (USFDA approved). A cross-sectional study was conducted over 1500 suspected SARS-CoV-2 patients. 100 real time-PCR confirmed patients were evaluated for pharmaceutical RDT kits based upon nasopharyngeal swab based kits. The SARS-CoV-2 nasopharyngeal swab based rapid diagnostic kit (NSP RDTs) analysis showed 78% reactivity. Among real time PCR confirmed negative subjects, 49.3% represented false positivity. The positive predictive analysis revealed 67.82%, while negative predictive values were 64.40%. The NSP RDTs showed limited sensitivities and specificities as compared to gold standard real time PCR. Valid and authentic detection of SARS-CoV-2 is deemed necessary for accurate COVID-19 surveillance across the globe. Current study highlights the potential consequences of inadequate detection of SARS-CoV-2 and emerging novel mutants, compromising vaccine preventable diseases. Current study emphasizes need to wake higher authorities including strategic organizations for designing adequate measures to prevent future SARS-CoV-2 epidemics.
first_indexed 2024-03-07T15:42:31Z
format Article
id doaj.art-5ed8132128f743a9bbb5b1475a85cf23
institution Directory Open Access Journal
issn 1678-4375
language English
last_indexed 2024-03-07T15:42:31Z
publishDate 2024-03-01
publisher Instituto Internacional de Ecologia
record_format Article
series Brazilian Journal of Biology
spelling doaj.art-5ed8132128f743a9bbb5b1475a85cf232024-03-05T07:40:21ZengInstituto Internacional de EcologiaBrazilian Journal of Biology1678-43752024-03-018410.1590/1519-6984.265550Analytical assessment of clinical sensitivity and specificities of pharmaceutical rapid SARS-CoV-2 detection nasopharyngeal swab testing kits in PakistanU. Saeedhttps://orcid.org/0000-0002-9740-0371R. Uppalhttps://orcid.org/0000-0003-1599-651XA. A. Khanhttps://orcid.org/0000-0001-7126-8010M. R. Uppalhttps://orcid.org/0000-0001-6147-788XZ. Z. Pirachahttps://orcid.org/0000-0001-8973-9773S. R. Uppalhttps://orcid.org/0000-0002-4116-1025Abstract Despite of the global unity against COVID-19 pandemic, the threat of SARS-CoV-2 variants on the lives of human being is still not over. SARS-CoV-2 pandemic has urged the need of rapid viral detection at earliest. To cope with gradually expanding scenario of SARS-CoV-2, accurate diagnosis is extremely crucial factor which should be noticed by international health organizations. Limited research followed by sporadic marketing of SARS-CoV-2 rapid pharmaceutical detection kits raises critical questions against quality assurance and quality control measures. Herein we aimed to interrogate effectivity and specificity analysis of SARS-CoV-2 pharmaceutical rapid detection kits (nasopharyngeal swab based) using conventional gold standard triple target real-time polymerase chain reaction (USFDA approved). A cross-sectional study was conducted over 1500 suspected SARS-CoV-2 patients. 100 real time-PCR confirmed patients were evaluated for pharmaceutical RDT kits based upon nasopharyngeal swab based kits. The SARS-CoV-2 nasopharyngeal swab based rapid diagnostic kit (NSP RDTs) analysis showed 78% reactivity. Among real time PCR confirmed negative subjects, 49.3% represented false positivity. The positive predictive analysis revealed 67.82%, while negative predictive values were 64.40%. The NSP RDTs showed limited sensitivities and specificities as compared to gold standard real time PCR. Valid and authentic detection of SARS-CoV-2 is deemed necessary for accurate COVID-19 surveillance across the globe. Current study highlights the potential consequences of inadequate detection of SARS-CoV-2 and emerging novel mutants, compromising vaccine preventable diseases. Current study emphasizes need to wake higher authorities including strategic organizations for designing adequate measures to prevent future SARS-CoV-2 epidemics.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1519-69842024000101101&lng=en&tlng=enSARS-CoV-2COVID-19PakistanNasopharyngeal Swabrapid testing
spellingShingle U. Saeed
R. Uppal
A. A. Khan
M. R. Uppal
Z. Z. Piracha
S. R. Uppal
Analytical assessment of clinical sensitivity and specificities of pharmaceutical rapid SARS-CoV-2 detection nasopharyngeal swab testing kits in Pakistan
Brazilian Journal of Biology
SARS-CoV-2
COVID-19
Pakistan
Nasopharyngeal Swab
rapid testing
title Analytical assessment of clinical sensitivity and specificities of pharmaceutical rapid SARS-CoV-2 detection nasopharyngeal swab testing kits in Pakistan
title_full Analytical assessment of clinical sensitivity and specificities of pharmaceutical rapid SARS-CoV-2 detection nasopharyngeal swab testing kits in Pakistan
title_fullStr Analytical assessment of clinical sensitivity and specificities of pharmaceutical rapid SARS-CoV-2 detection nasopharyngeal swab testing kits in Pakistan
title_full_unstemmed Analytical assessment of clinical sensitivity and specificities of pharmaceutical rapid SARS-CoV-2 detection nasopharyngeal swab testing kits in Pakistan
title_short Analytical assessment of clinical sensitivity and specificities of pharmaceutical rapid SARS-CoV-2 detection nasopharyngeal swab testing kits in Pakistan
title_sort analytical assessment of clinical sensitivity and specificities of pharmaceutical rapid sars cov 2 detection nasopharyngeal swab testing kits in pakistan
topic SARS-CoV-2
COVID-19
Pakistan
Nasopharyngeal Swab
rapid testing
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1519-69842024000101101&lng=en&tlng=en
work_keys_str_mv AT usaeed analyticalassessmentofclinicalsensitivityandspecificitiesofpharmaceuticalrapidsarscov2detectionnasopharyngealswabtestingkitsinpakistan
AT ruppal analyticalassessmentofclinicalsensitivityandspecificitiesofpharmaceuticalrapidsarscov2detectionnasopharyngealswabtestingkitsinpakistan
AT aakhan analyticalassessmentofclinicalsensitivityandspecificitiesofpharmaceuticalrapidsarscov2detectionnasopharyngealswabtestingkitsinpakistan
AT mruppal analyticalassessmentofclinicalsensitivityandspecificitiesofpharmaceuticalrapidsarscov2detectionnasopharyngealswabtestingkitsinpakistan
AT zzpiracha analyticalassessmentofclinicalsensitivityandspecificitiesofpharmaceuticalrapidsarscov2detectionnasopharyngealswabtestingkitsinpakistan
AT sruppal analyticalassessmentofclinicalsensitivityandspecificitiesofpharmaceuticalrapidsarscov2detectionnasopharyngealswabtestingkitsinpakistan